Document Preview Unavailable
Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam
Pham Van Luan; Le, Tuan Anh; Pham Cam Phuong; Hoa Nguyen Thi Thai; Tu, Do Anh; et al. Therapeutic Advances in Medical Oncology Vol. 16, (Jan 2024).You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library